Copyright
©The Author(s) 2025.
World J Diabetes. Jan 15, 2025; 16(1): 92711
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.92711
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.92711
Figure 5 Mizagliflozin intervention improved the lactate dehydrogenase levels of mesangial cells caused by high glucose better than canagliflozin.
A: Lactate dehydrogenase levels; B: Cell Counting Kit-8 test; C: Western blot of tumour necrosis factor-α in high glucose with varying levels of mizagliflozin (MIZ); D: Western blot of interleukin-1β in high glucose with varying levels of MIZ; E: Western blot of transforming growth factor β in high glucose with varying levels of MIZ. The values are presented as the mean ± standard error of the mean. aP < 0.05; bP < 0.01. MIZ: Mizagliflozin; IL: Interleukin; TGF: Transforming growth factor; TNF: Tumour necrosis factor; HG: High glucose.
- Citation: Lin ZM, Gao HY, Shi SH, Li YT. Mizagliflozin ameliorates diabetes induced kidney injury by inhibitor inhibit inflammation and oxidative stress. World J Diabetes 2025; 16(1): 92711
- URL: https://www.wjgnet.com/1948-9358/full/v16/i1/92711.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i1.92711